NHS image

NHS searches for healthcare innovators

January 8, 2015
Medical Communications, Sales and Marketing NHS, UK, innovation, programme, sir bruce keogh

NHS England and medical director Sir Bruce Keogh have launched an NHS Innovation Accelerator Programme. The initiative will invite healthcare …

darren_carroll

Lilly appoints head of business development

January 8, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing darren carroll, lilly

Eli Lilly has promoted Darren Carroll to senior vice president of its corporate business development unit. Carroll has fulfilled the …

Afinitor image

Exclusive: Novartis drug struck off cancer drugs fund

January 8, 2015
Sales and Marketing Afinitor, Jevtana, NHS, NHS England, NICE, Novartis, Sanofi, everolimus

Novartis’ Afinitor (everolimus) will be removed from the Cancer Drugs Fund list when NHS England announces which drugs it can …

Gilead acquires Phenex liver disease drugs

January 7, 2015
Research and Development, Sales and Marketing Farnesoid X Receptor, Gilead, liver, nafld, nash, phenex

Gilead Sciences has acquired Phenex Pharmaceuticals’ development programme for the treatment of serious liver diseases. The US biopharma firm will …

Amgen image

Amgen and Novartis start cancer immunotherapy push

January 7, 2015
Research and Development, Sales and Marketing Amgen, Caribou Biosciences, Intellia Therapeutics, Novartis, kite pharma

Amgen and Novartis have launched new licensing agreements with biotech companies that they hope will lead to the development of …

danielle_guildford

Liberation Unlimited promotes Danielle Guildford-Sharp

January 7, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston, Danielle Guildford-Sharp, health unlimited, liberation unlimited

UK marketing and communications agency Liberation Unlimited has promoted Danielle Guildford-Sharp to the role of account manager. Since joining Liberation …

Director General of EFPIA: “Pan-European HTA necessary”

January 6, 2015

London, January 5 2015: Richard Bergström, Director General, EFPIA argued passionately in favour of the homogenisation of European HTA bodies …

Janssen image

Vectura and J&J shake on asthma/COPD deal

January 6, 2015
Research and Development, Sales and Marketing COPD, J&J, JJ, Janssen, asthma, johnson, rezolsta, tybost, vectura

British firm Vectura has entered an agreement with Johnson & Johnson’s pharma unit Janssen to develop therapies for asthma and …

Pfizer buys vaccine developer Redvax

January 6, 2015
Research and Development, Sales and Marketing Pfizer, Vaccine, cmv, herpes, redbiotec, redvax, virus

Adding to its latest string of deals Pfizer has acquired vaccine developer Redvax – the pre-clinical arm of Swiss company …

BMS image

BMS launches new fibrosis research collaboration

January 6, 2015
Research and Development, Sales and Marketing BMS, BMS-986020, calibr, california, fibrosis, fibrotic

Bristol-Myers Squibb is entering into an agreement with the California Institute for Biomedical Research to develop new treatments for fibrotic …

Valeant pharma

Valeant recalls drug used on hospitalised infants

January 6, 2015
Manufacturing and Production, Sales and Marketing Actavis, Allergan, FDA, Valeant, manufacturing, recall, ribavirin, virazole

North American drug firm Valeant Pharmaceuticals has issued a voluntary nationwide recall of Virazole due to microbial contamination. Virazole (ribavirin …

Ebola image

UK nurse with Ebola in ‘critical condition’

January 6, 2015
Research and Development, Sales and Marketing Africa, Ebola, GSK, Mapp, WHO, cafferky, johnson, zmapp

A British nurse that was diagnosed with Ebola last week is said to be in a critical condition at the …

janet_valentine

MRC head joins CPRD as director

January 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MHRA, MRC, cprd, janet valentine

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced an appointment of a new director for The Clinical Practice …

moxifloxacin

Next-generation Cempra antibiotic meets endpoints

January 5, 2015
Research and Development, Sales and Marketing Antibiotics, FDA, cempra, moxifloxacin, solitaire-oral

Cempra Pharmaceuticals has become the first company to publish results from a Phase III study completed under FDA regulations governing …

Pharma industry set for bumper 2015

January 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2015, FDA, bumper, harvoni, opdivo, pharma, sovaldi

Industry analysts predict 2015 will be another year of growth for the pharma, after approvals of new drugs soared to …

Publishing image

Medical publishing: can we rely on it?

January 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, csr, journals, medical publishing, peer, publishing, transparency

The explosive proliferation of journals suggests that medical publishing is an attractive business. But it’s not without its critics, as …

alan_schoenbart

New CFO for Echo Therapeutics

January 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing alan schoenbart, echo therapeutics

US medical device firm Echo Therapeutics has appointed Alan Schoenbart as its chief financial officer.Schoenbart who has more than 30 …

Novo image

Novo Nordisk obesity drug gets FDA nod

December 24, 2014
Sales and Marketing FDA, Novo Nordisk, Victoza, diabetes, liraglutide, saxenda

The US Food and Drug Administration has shown Novo Nordisk’s obesity drug Saxenda the green light to aid chronic weight …

NHS image

NHS plans bashed over cancer and heart disease

December 24, 2014
Research and Development, Sales and Marketing Cancer, England, NHS, Simon Stevens, funding, heart

Hundreds of healthcare experts have signed an open letter to NHS chief executive Simon Stevens calling for him to scrap …

jonathon-kellerman

Actavis hires senior head from PwC

December 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Jonathon Kellerman, pwC

Jonathon Kellerman has joined Ireland-based speciality pharma firm Actavis as its executive vice president and global chief compliance officer.  Reporting …

The Gateway to Local Adoption Series

Latest content